Adlai Nortye Group Ltd. SEC filings ANL
Adlai Nortye Group Ltd. has 114 filings in SEC EDGAR's recent list, going back to Dec 21, 2022. Its latest annual report, Form 20-F, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 28, 2026 | Oct 28, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| EFFECT | Filing | Sep 15, 2026 | — |
| S-8 POS | Registration statement | Sep 11, 2026 | — |
| S-8 POS | Registration statement | Sep 11, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form f-3 | Sep 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 6-K | Current report (foreign issuer) | Aug 19, 2026 | Aug 19, 2026 |
| 6-K | Current report (foreign issuer) | Aug 14, 2026 | Aug 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 424B7 | Prospectus supplement | Jul 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 17, 2026 | Jul 16, 2026 |
| EFFECT | Filing | Apr 28, 2026 | — |
| CORRESP | Letter to the SEC | Apr 24, 2026 | — |
| F-3/A | Amendment no. 2 to form f-3 | Apr 24, 2026 | — |
| F-3/A | Amendment no. 1 to form f-3 | Apr 23, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 16, 2026 | Apr 16, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 10, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2026 | Apr 1, 2026 |
| UPLOAD | Letter from the SEC | Mar 10, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 6-K | Current report (foreign issuer) | Feb 3, 2026 | Feb 3, 2026 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 29, 2025 |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| S-8 | Employee stock plan registration | Sep 16, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 9, 2025 | Jul 9, 2025 |
| 6-K | Current report (foreign issuer) | May 30, 2025 | May 30, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | May 12, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Feb 27, 2025 | — |
| 20-F/A | Amended annual report (foreign issuer) | Feb 14, 2025 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Feb 14, 2025 |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 2, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 31, 2024 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Dec 18, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 8, 2024 | Aug 8, 2024 |
| 6-K | Current report (foreign issuer) | Jul 3, 2024 | Jul 3, 2024 |
| 6-K | Current report (foreign issuer) | Jun 27, 2024 | Jun 27, 2024 |
| 6-K | Current report (foreign issuer) | May 24, 2024 | May 23, 2024 |
| S-8 | Employee stock plan registration | May 13, 2024 | — |
| 20-F | Annual report (foreign issuer) | Apr 19, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Apr 2, 2024 | Apr 2, 2024 |
| 424B4 | Prospectus | Sep 29, 2023 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| CERT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| F-1/A | Filing | Sep 27, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| F-1/A | Filing | Sep 12, 2023 | — |
| 8-A12B | Filing | Aug 18, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2023 | — |
| CORRESP | Letter to the SEC | Aug 14, 2023 | — |
| F-1/A | Filing | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| F-1/A | Filing | Aug 10, 2023 | — |
| 8-A12B | Filing | Aug 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 27, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Jul 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2023 | — |
| DRSLTR | Filing | Jun 22, 2023 | — |
| DRS/A | Filing | Jun 22, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| DRSLTR | Filing | May 11, 2023 | — |
| DRS/A | Filing | May 11, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| DRSLTR | Filing | Apr 14, 2023 | — |
| DRS/A | Filing | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2023 | — |
| DRSLTR | Filing | Feb 27, 2023 | — |
| DRS/A | Filing | Feb 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2023 | — |
| DRSLTR | Filing | Dec 21, 2022 | — |
| DRS | Filing | Dec 21, 2022 | — |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Singapore
- Headquarters
- Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944552
- Former names
- Adlai Nortye Ltd. (until Aug 19, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.